Tagged Content
Everything on the platform tagged with biomedical-engineering.
Yahya Aqel is the co-founder and CEO of Aumet, MENA's largest B2B healthcare marketplace and AI-first procurement operating system. A biomedical engineer turned serial entrepreneur, he has founded five health tech startups across Silicon Valley, the Middle East, and Western Europe — two of which resulted in successful exits. Aumet, backed by Emkan Capital and others, has raised $21.84M to date and processes over $1 billion in gross merchandise volume annually, connecting 12,000+ pharmacies with 1,000+ pharmaceutical suppliers across Jordan, Egypt, and Saudi Arabia.
Paxton Maeder-York is the founder of Alife Health, an AI platform for IVF clinics that has raised $31.5M and raised the standard for data-driven fertility care. A Harvard-trained biomedical engineer and MBA, he previously helped build surgical robotics at Auris Health (acquired by J&J for $3.4B) and worked in product at Google X. In 2020, driven in part by the fact that his younger brother is an IVF baby, he founded Alife to apply machine learning to embryo selection, hormone dosing, and lab scheduling. By 2024 the company had launched five products, earned recognition from Fast Company and the World Economic Forum, and achieved a leadership transition - Paxton stepping into a board role as Melissa Teran took the CEO seat.

Tony Cueva Bravo is a Venture Partner at Hustle Fund, angel investor, and the founder of Emerging Fintech - a weekly newsletter and podcast covering frontier fintech across Latin America, Asia, and Africa. A Peruvian-born engineer who earned his MS in Biomedical Engineering from the University of Michigan, Tony has lived and worked across three continents, driven 50% MoM growth at Rebill (the Stripe of LatAm), won dual startup competitions in Peru and Chile, and built a reputation as one of the sharpest fintech voices in emerging markets. He invests at the pre-seed stage and serves as a fractional operator for early-stage founders who need a thought partner to unlock growth bottlenecks.